Don't be fooled, page-21

Thanks for your reply. I think I get where you are coming from and I am interested and grateful for your view of the industry as a whole. If I can para-phase, I think you're saying the valuations are full but that doesn't exclude a good result. Just that the risk is on the downside?

Overall I am more confident of Fielding's ability to integrate but you have to balance the risk. I think all the regular posters on here share the view that RXP is not the most sought after asset in this class so any hiccup would me magnified in the fall.

Which neatly summaries @afterlife post as well, or at least my reading of it...so not so far apart.

Thanks